North America Bone Growth Stimulators Market

North America Bone Growth Stimulators Market Size (2022 to 2027)

The North American Bone Growth Stimulators Market was valued at USD 0.37 Billion in 2022 and estimated to be growing at a CAGR of 5.5% to reach USD 0.48 Billion by 2027 during the forecast period.

Bone growth stimulators are used to make up for the delay in fracture healing. They speed up the bone-healing without causing any electrical shocks when used. An internal bone growth stimulator is kept on the bone's fusion site for about 6 to 12 months, releasing small electrical currents. The external bone growth stimulator is worn externally and does not need any surgical implantation.

The market is estimated to grow significantly during the specified period and in the years to follow.

North America Bone-growth stimulators market is propelled by factors like the growing geriatric population, rising incidences of arthritis and injuries caused by sports, and increasing demand for non-invasive spinal surgery techniques. But, factors like the easy availability of other treatments, doubtful efficiency, problems in the medical device, and competition from bone grafting act as restraints for the growth of the bone growth stimulators market.

This research report on the North America Bone Growth Stimulators Market has been segmented and sub-segmented into the following categories.

By Product: 

• Bone Growth Stimulation Devices
  • External
  • Implanted
  • Ultrasonic
• Bone Morphogenetic Proteins (BMP)
• Platelet-rich Plasma (PRP)

By Application: 

• Spinal Fusion Surgeries
• Delayed Union & Non-union Bone Fractures
• Oral and Maxillofacial Surgeries
• Other Applications

By End User: 

• Hospitals and Clinics
• Home Care
• Academic & Research Institutes
• CROs

By Country: 

• The U.S.
• Canada
• Rest of North America

Geographically, the North American bone growth stimulators market accounted most significant share in the global market in 2020, and it is likely to continue its dominance during the forecast period. The market growth is attributed to the availability of advanced healthcare infrastructure, favorable reimbursement policies, and the adoption of advanced technology in the healthcare sector.

The U.S. bone growth stimulators market is expected to dominate the North American market during the forecast period. The market had a significant share over the forecast period. However, it is anticipated to witness a rapid share during the forecast period. The increasing prevalence of spinal disorders, growing preference for minimally invasive orthopedic procedures, and rise in disposable income of the individuals are fuelling the market growth—the other factors such as senior population. Therefore, the senior population is considered one of the major growth contributors in the market. In addition, the rising population is more exposed to chronic disorders such as diabetes, obesity, and smoking, positively influencing the market growth.

On the other hand, the Canadian bone growth stimulators market is projected to account for a promising share in the bone growth stimulators market. An increase in the prevalence of osteoporosis and VCFs has resulted in a rise in demand for bone growth stimulators, driving the market growth.

KEY MARKET PLAYERS:

A few promising companies operating in the North America Bone Growth Stimulators Market are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.